Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Nanosci Nanotechnol ; 5(1): 92-5, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15762166

RESUMO

The development of low cost hierarchical porous materials based upon the zeolitisation of diatomaceous earth for fluid waste benification is described. Two preparative approaches invole: first, using the diatom as a support for zeolite nanocrystals; second, direct pseudomorphic transformation of the diatom into a zeolite. These hierarchical porous materials are potentially useful for important industrial processes in ion-exchange, catalysis and waste benefication.


Assuntos
Cristalização/métodos , Diatomáceas/química , Diatomáceas/ultraestrutura , Nanoestruturas/química , Nanoestruturas/ultraestrutura , Zeolitas/química , Tamanho da Partícula , Porosidade
2.
J Cardiovasc Pharmacol ; 38(3): 337-46, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11486238

RESUMO

The pharmacology of selenium is of much interest because selenium deficiency has been linked to cardiovascular diseases, cancer, and arthritis, and selenoenzymes are critical cellular antioxidants. We have previously reported that phenyl-2-aminoethylselenide (PAESe) and its derivatives represent a novel class of selenium-based antihypertensive agents that exhibit unique biochemical and pharmacologic properties. We now report on experiments designed to probe the hemodynamic mechanism of action of these compounds in spontaneously hypertensive rats (SHR). A noninvasive pulsed Doppler ultrasound probe was used to measure peak blood flow velocity in the aortic arch from the right second intercostal space. PAESe was found to increase peak aortic blood flow velocity (+44%), heart rate (+16%), and blood flow acceleration (+105%), while decreasing left ventricular ejection time (LVET) (-37%) concomitant with a decrease in mean arterial pressure (-54%). These results were compared with the known vasodilator hydralazine, which had similar effects on mean arterial pressure (MAP) and peak velocity but caused an increase in LVET (+42%) and a decrease in heart rate (-18%). Taken together, our results suggest that PAESe decreases blood pressure via a decrease in peripheral resistance, which overcomes the initial increase in heart rate and acceleration to give a net decrease in MAP.


Assuntos
Anti-Hipertensivos/farmacologia , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Pressão Sanguínea/efeitos dos fármacos , Etilaminas/farmacologia , Hipertensão/tratamento farmacológico , Compostos Organosselênicos/farmacologia , Ultrassonografia Doppler de Pulso , Animais , Esquema de Medicação , Etilaminas/administração & dosagem , Frequência Cardíaca/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Humanos , Hidralazina/farmacologia , Hipertensão/fisiopatologia , Compostos Organosselênicos/administração & dosagem , Ratos , Ratos Endogâmicos SHR
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...